NCT00065143View on ClinicalTrials.gov

Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 23, 2003

Primary Completion Date

February 22, 2006

Study Completion Date

February 22, 2006

Conditions
Leukemia, MyeloidMyelodysplastic Syndromes
Interventions
DRUG

clofarabine

DRUG

Ara-C

Trial Locations (1)

77030

The University of Texas M.D. Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

Genzyme, a Sanofi Company

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER

NCT00065143 - Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome | Biotech Hunter | Biotech Hunter